BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241101T083000
DTEND;TZID=Europe/Helsinki:20241103T123000
DTSTAMP:20260504T021802
CREATED:20241015T190657Z
LAST-MODIFIED:20250608T081113Z
UID:10000037-1730449800-1730637000@oncodaily.com
SUMMARY:ESH 4th How to Diagnose and Treat Lymphoma
DESCRIPTION:ESH 4th How to Diagnose and Treat Lymphoma will be held from November 1-3\, 2024 at Stockholm\, Sweden. \nESH (European School of Haematology)’s ‘How to Diagnose and Treat’ meetings are specialized\, disease-specific events designed to provide in-depth insights into the latest advances in diagnostics and clinical management of various hematological conditions. These meetings focus on the presentation and analysis of real-life clinical cases\, offering attendees a practical\, case-based learning experience. \nInteractive voting technology is incorporated as a self-assessment tool\, enabling participants to evaluate their understanding while fostering increased scientific engagement and discussion. Through this approach\, ESH promotes a dynamic exchange of ideas between experts and clinicians\, helping to advance best practices in patient care. \nFor more information and registration visit here
URL:https://oncodaily.com/event/165584
LOCATION:Hotel Clarion\, Ringvägen 98\, Stockholm\, 10460\, Sweden
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/7.-LYMPHOMA-2024-ShockLogic-e1729018656497.png
ORGANIZER;CN="European School of Haematology":MAILTO:info(at)esh.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241105T180000
DTEND;TZID=America/Halifax:20241105T180000
DTSTAMP:20260504T021802
CREATED:20241025T133325Z
LAST-MODIFIED:20250608T081121Z
UID:10000061-1730829600-1730829600@oncodaily.com
SUMMARY:Lung cancer highlights from the ESMO Congress 2024 by SPCC
DESCRIPTION:Lung cancer highlights from the ESMO Congress 2024 by SPCC will take place at November 5th\, 2024. \nIt is a live webinar by SPCC which will be futuring Aleksandra Filipovic\, Alfredo Addeo\, Christian Rolfo. The landscape of treatment for thoracic malignancies has undergone significant and rapid advancements in recent years. New therapies\, including targeted treatments\, immunotherapies\, and innovative surgical techniques\, are now available\, having a profound and positive impact on patients’ lives by improving outcomes and quality of care. However\, with the fast-paced development and the vast amount of clinical data being generated from ongoing research and presented at international conferences\, it can be challenging for clinicians and healthcare professionals to stay up to date with the latest evidence and treatment options. \nFor registration visit here
URL:https://oncodaily.com/event/171740
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Webinar_05_Nov_1920x1080.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241106T070000
DTEND;TZID=America/Halifax:20241106T210000
DTSTAMP:20260504T021802
CREATED:20241031T194019Z
LAST-MODIFIED:20250608T081127Z
UID:10000065-1730876400-1730926800@oncodaily.com
SUMMARY:4th APHOG & SIOP Asia Joint Scientific Symposium 2024 on Retinoblastoma
DESCRIPTION:The 4th APHOG & SIOP Asia Joint Scientific Symposium 2024 will focus on the topic of Retinoblastoma. This event will take place via Zoom on Wednesday\, November 6\, 2024. The session will be held from 07:00 to 09:00 EST (USA)\, 16:30 to 18:30 IST (India)\, and 20:00 to 22:00 JST (Japan). \nThe organizers of the event are the Asian Continental Branch International Society of Pediatric Oncology (SIOP Asia) and the Asian Pediatric Hematology and Oncology Group (APHOG). For more information about the agenda\, check the flyer. \nJoin this important symposium\, where experts from across the region will share insights and advancements in research and treatment. Don’t miss this opportunity to engage in meaningful discussions and expand your knowledge on this critical topic! \nMake sure to register here. \nFind more information featuring SIOP Asia at OncoDaily.
URL:https://oncodaily.com/event/siopasia176544
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/siopasia.jpg
ORGANIZER;CN="SIOP Asia":MAILTO:info@siop-online.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241107T080000
DTEND;TZID=Europe/Helsinki:20241110T170000
DTSTAMP:20260504T021802
CREATED:20241029T192326Z
LAST-MODIFIED:20250608T081133Z
UID:10000064-1730966400-1731258000@oncodaily.com
SUMMARY:16th European Multidisciplinary Congress on Urological Cancers EMUC 2024
DESCRIPTION:16th European Multidisciplinary Congress on Urological Cancers EMUC 2024 will take place in Lisbon\, Portugal\, from 7 to 10 November 2024. \nTop experts in medical oncology\, pathology\, radiation oncology\, radiology\, nuclear medicine\, and urology gathered at the EMUC24 congress from 7 to 10 November 2024 to share insights on best practices\, major trial developments\, and breakthroughs. \nThe scientific programme featured in-depth lectures\, practical hands-on courses\, and dynamic multidisciplinary case discussions. EMUC24 highlighted cutting-edge therapies\, current practices\, controversies\, and emerging technologies in GU cancer treatment. \nThis multidisciplinary approach was achieved through collaboration with the European Society for Medical Oncology (ESMO)\, the European Society for Radiotherapy and Oncology (ESTRO)\, and the European Association of Urology (EAU)\, alongside contributions from the Kidney Cancer Association (KCA) on recent kidney cancer advancements.
URL:https://oncodaily.com/event/174661
LOCATION:Lisbon Congress Centre\, Praça das Indústrias 1\, Lisbon\, 1300-307\, Portugal
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Esmou.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241107T090000
DTEND;TZID=Europe/Helsinki:20241108T000000
DTSTAMP:20260504T021802
CREATED:20241020T202240Z
LAST-MODIFIED:20250608T081905Z
UID:10000049-1730970000-1731024000@oncodaily.com
SUMMARY:Frontiers in gynaecological oncology
DESCRIPTION:Frontiers in gynaecological oncology will be held at Pristina\, Kosovo from November 7-8\, 2024. \nThe European School of Oncology offers support to Clinical Institutes through its Visiting Professorship Meeting (VPM) initiative. This program is designed for renowned clinical oncology centers whose medical teams are interested in participating in internal educational meetings conducted in English. \n 
URL:https://oncodaily.com/event/168011
LOCATION:Pristina\, Kosovo\, Pristina\, 10000
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Untitled-2ի-1.jpg
ORGANIZER;CN="European School of Oncology":MAILTO:eso@eso.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241108T203000
DTEND;TZID=Europe/Helsinki:20241112T130000
DTSTAMP:20260504T021802
CREATED:20241025T133432Z
LAST-MODIFIED:20250608T081913Z
UID:10000052-1731097800-1731416400@oncodaily.com
SUMMARY:15th ESO-EONS Masterclass in Oncology Nursing
DESCRIPTION:15th ESO-EONS Masterclass in Oncology Nursing will be held on San Servolo (Venice)\, Italy from November 8-11\, 2024. \nThe ESO Masterclass in Oncology Nursing is an intensive programme for European cancer nurses\, offering three and a half days of immersive oncology education. It focuses on enhancing clinical skills\, improving patient care\, and advancing clinical leadership. \nNursing sessions will cover key areas such as patient assessment\, safety\, communication\, symptom management\, and nursing research. Case studies presented by participants will explore specialized care practices. \nJoint sessions with physicians emphasize the need for interdisciplinary collaboration in cancer care\, while practical training in case studies will focus on essential skills for patient care management. \nDeadline for applications: Friday 24 May 2024
URL:https://oncodaily.com/event/168621
LOCATION:San Servolo\, San Servolo\, 20100\, Italy
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/Untitled-1f.png
ORGANIZER;CN="European School of Oncology":MAILTO:eso@eso.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241111T083000
DTEND;TZID=UTC:20241115T220000
DTSTAMP:20260504T021802
CREATED:20241101T190154Z
LAST-MODIFIED:20250608T081924Z
UID:10000066-1731313800-1731708000@oncodaily.com
SUMMARY:London Global Cancer Week 2024
DESCRIPTION:London Global Cancer Week 2024 will be held from November 11-15\, 2024 at London\, UK. \nIn 2016\, the Royal Society of Medicine Oncology Section initiated annual one-day meetings aimed at improving global cancer outcomes. This evolved into London Global Cancer Week in 2019\, expanding the format to a week-long series of multidisciplinary meetings that address the global challenges of cancer. Since its launch\, London Global Cancer Week has grown annually\, and in 2024\, it will feature more presentations and speakers than ever before. \nLondon Global Cancer Week will feature a diverse series of events hosted by experts committed to improving global cancer outcomes showcasing innovative solutions and progress in cancer control initiatives fostering coherent policymaking through holistic discussions acting as a catalyst for positive change benefiting individuals and families affected by cancer with no charge for organizations to present or attendees to participate. \nFor programme of the event\, visit here.
URL:https://oncodaily.com/event/176990
LOCATION:The Royal Marsden Education and Conference Centre\, Fulham Road London SW3 6JJ\, London\, United Kingdom
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/download-7.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241113T000000
DTEND;TZID=America/Halifax:20241115T000000
DTSTAMP:20260504T021802
CREATED:20241025T133346Z
LAST-MODIFIED:20250608T081918Z
UID:10000059-1731456000-1731628800@oncodaily.com
SUMMARY:42nd Annual CFS: Innovative Cancer Therapy for Tomorrow
DESCRIPTION:42nd Annual CFS: Innovative Cancer Therapy for Tomorrow will be held from November 13-15\, 2024 at New York\, USA. \n\n\n\n\nEntering its 42nd year\, the Chemotherapy Foundation Symposium (CFS) remains a premier event that brings together thousands of healthcare professionals for a dynamic 3-day conference focused on delivering cutting-edge\, evidence-based cancer care. Esteemed faculty from around the world will share their expertise on the latest developments in cancer therapeutics\, providing attendees with a unique opportunity to explore how new and innovative approaches can be integrated into current treatment paradigms to improve care for cancer patients. \nWith ongoing rapid progress in the management of solid and hematologic malignancies\, the past year has seen significant shifts in practice\, with new diagnostic\, therapeutic\, and supportive care strategies being implemented. At CFS\, participants will gain critical insights into optimized treatments\, including chemotherapies\, targeted therapies\, immunotherapies\, and multimodal approaches that are shaping the future of oncology care.
URL:https://oncodaily.com/event/170152
LOCATION:New York Hilton Midtown\, Grand Ballroom (Located on the 3 rd Floor) 1335 Avenue of the Americas\, New York\, 10019\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/s6x5uyhoplpn-CFS24TIDetail800x450.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241114T080000
DTEND;TZID=America/New_York:20241116T163000
DTSTAMP:20260504T021802
CREATED:20241007T145835Z
LAST-MODIFIED:20250608T081857Z
UID:10000013-1731571200-1731774600@oncodaily.com
SUMMARY:2024 Latin America Conference on Lung Cancer
DESCRIPTION:The IASLC Latin America Conference on Lung Cancer (LALCA24) will be held at the Grand Hyatt Bogotá in Bogotá\, Colombia on November 14-16. \nLALCA is a vibrant conference with a rich history that will showcase the latest research\, a variety of relevant topics\, and educational sessions led by top experts. \nThis event offers an excellent chance to connect with professionals from different fields who are dedicated to thoracic cancers\, while also gaining insights into the newest advancements in prevention\, detection\, and treatment through innovative data presentations. \nThe event is organized by the International Association for the Study of Lung Cancer (IASCL). \nFor more information featuring LALCA24 visit OncoDaily.com.
URL:https://oncodaily.com/event/159102
LOCATION:Grand Hyatt Bogotá\, Cl. 24a #57 – 60\, Bogota\, Colombia
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/GPZHUUqaAAAnKPv.jpg
ORGANIZER;CN="International Association for the Study of Lung Cancer (IASCL)":MAILTO:info@iaslc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241114T120000
DTEND;TZID=America/Halifax:20241117T120000
DTSTAMP:20260504T021802
CREATED:20241102T163359Z
LAST-MODIFIED:20250608T081850Z
UID:10000067-1731585600-1731844800@oncodaily.com
SUMMARY:The 2024 China Conference on Integrative Oncology
DESCRIPTION:The 2024 China Conference on Integrative Oncology will be held from November 14-17\, 2024 at Xi’an\, China. \nOrganized by the China Anti-Cancer Association\, Xijing Hospital of the Air Force Medical University\, and others\, the conference is expected to draw over 40\,000 domestic and 20\,000 international participants. Under the theme “Cancer Prevention and Treatment\, Winning in Integration\,” the event will feature three main sections: “conference\,” “exhibition\,” and “production\,” encompassing academic exchanges\, achievement showcases\, and industrial collaboration. Oncology professionals are encouraged to submit papers and actively participate in this important event. \n 
URL:https://oncodaily.com/event/177006
LOCATION:Xi’an\, China\, Xi'an\, 710000\, China
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/download.png
ORGANIZER;CN="China Anti-Cancer Association":MAILTO:intl@caca.org.cn.
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241115T000000
DTEND;TZID=Europe/Helsinki:20241117T000000
DTSTAMP:20260504T021802
CREATED:20241016T122837Z
LAST-MODIFIED:20250608T081843Z
UID:10000038-1731628800-1731801600@oncodaily.com
SUMMARY:ESH-EBMT-EHA-IPIG 3rd Translational Research Conference
DESCRIPTION:The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes will be held at Paris\, France from November 15-17\, 2024. \nIt will offer valuable insights for both clinical and non-clinical scientists\, including M.D.s and Ph.D.s of all levels\, who are interested in the biology\, pathophysiology\, diagnosis\, and treatment of bone marrow failure syndromes (BMFS) and predisposition syndromes. The conference will address both acquired and inherited BMFS in adults and children\, with a particular focus on emerging principles and innovative treatment strategies. \nAs is customary for ESH\, the event will prioritize accessible interactions between young researchers and established experts\, as well as between clinicians and basic scientists. Workshops with experts and poster walks will emphasize key topics and provide opportunities for in-depth discussion. The distinguished faculty will ensure a high standard of clinical\, translational\, and basic research is maintained throughout the conference. \nFor Registration Visit Here
URL:https://oncodaily.com/event/165887
LOCATION:Espace Saint-Martin\, 199 Bis r St Martin\, 75003 Paris\, Paris\, 75001\, Sweden
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/BMFS2024_banner_NEW.png
ORGANIZER;CN="European School of Haematology":MAILTO:info(at)esh.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241120T090000
DTEND;TZID=Europe/Brussels:20241121T183000
DTSTAMP:20260504T021802
CREATED:20240927T173111Z
LAST-MODIFIED:20250608T081836Z
UID:10000006-1732093200-1732213800@oncodaily.com
SUMMARY:European Cancer Summit 2024
DESCRIPTION:The European Cancer Summit 2024 will once again unite the cancer community in accelerating efforts against a most relentless disease. Experts\, patients and policymakers will explore new innovative solutions to pressing challenges faced by healthcare systems across Europe and propose new opportunities in cancer research. \nThis year’s European Cancer Summit takes place on 20 & 21 November\, in Brussels & online. \n 
URL:https://oncodaily.com/event/european-cancer-summit-2024
LOCATION:Radisson Collection Hotel Brussels\, 47 Rue du Fossé Aux Loups\, Brussels\, Brussels\, 1000\, Belgium
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/09/ECS.jpg
ORGANIZER;CN="European Cancer Organization":MAILTO:summit@europeancancer.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241127T180000
DTEND;TZID=America/Halifax:20241127T193000
DTSTAMP:20260504T021802
CREATED:20241120T051946Z
LAST-MODIFIED:20250608T081829Z
UID:10000071-1732730400-1732735800@oncodaily.com
SUMMARY:Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC
DESCRIPTION:Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC will be held at November 27\, 2024. \nIt is a live webinar by SPCC and the event will feature presentations on the latest advancements in breast cancer treatment\, with an introduction by Fiorita Poulakaki from Greece. Michael Gnant from Austria will discuss the de-escalation and escalation of surgery\, radiotherapy\, and adjuvant treatments. Stephen Johnston from the UK will focus on personalizing adjuvant endocrine therapy\, exploring current perspectives and future directions. Following the talks\, there will be a 10-minute discussion and Q&A session\, allowing participants to engage with the speakers. \nThe event will conclude with closing remarks by Fiorita Poulakaki\, summarizing the key takeaways.
URL:https://oncodaily.com/event/188391
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/Webinar_27_Nov_1920x1080.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
END:VCALENDAR